Clinical performance of tumor-informed versus tumor-agnostic ctDNA assays for colorectal cancer recurrence: A systematic review and diagnostic accuracy meta-analysis
Year: 2025
Type: review
Language: en
Topic: Cancer Genomics and Diagnostics
Authors and affiliations:
raw_author_name: Daniel G. Camblor
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain
raw_author_name: Belén Martínez-Castedo
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain
raw_author_name: Jorge Martín-Arana
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain
raw_author_name: Francisco Gimeno-Valiente
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Cancer Evolution and Genome Instability Laboratory, University College London Cancer Institute, London, United Kingdom
raw_author_name: Blanca García-Micó
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain
raw_author_name: Francisco Martínez-Picó
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain
raw_author_name: Víctor Seguí
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain
raw_author_name: Miguel García-Bartolomé
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain
raw_author_name: Diego González
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain
raw_author_name: Alejandro Guimera
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain
raw_author_name: Marisol Huerta
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain
raw_author_name: Susana Roselló
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain
raw_author_name: Valentina Gambardella
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain
raw_author_name: Desamparados Roda
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain
raw_author_name: Leontios Pappas
raw_affiliation_strings: Division of Hematology/Oncology, Mass General Brigham Cancer Center, Harvard Medical School, Boston, MA, USA
raw_author_name: Aparna Parikh
raw_affiliation_strings: Division of Hematology/Oncology, Mass General Brigham Cancer Center, Harvard Medical School, Boston, MA, USA
raw_author_name: Juan Antonio Carbonell-Asins
raw_affiliation_strings: Biostatistics Unit, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain
raw_author_name: Andrés Cervantes
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain
raw_author_name: Noelia Tarazona
raw_affiliation_strings: Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain; Division of Hematology/Oncology, Mass General Brigham Cancer Center, Harvard Medical School, Boston, MA, USA